Phase 2 Advanced Pancreatic Cancer Clinical Trials
10 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–10 of 10 trials
Recruiting
Phase 2
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
Endometrial CancerLocally Advanced Malignant Solid NeoplasmMetastatic Malignant Solid Neoplasm+10 more
Rahul Aggarwal89 enrolled3 locationsNCT03682289
Recruiting
Phase 2
A Phase II Study of HRS-4642 Combined With AG (Nab-paclitaxel and Gemcitabine) as Conversion Therapy for Locally Advanced Pancreatic Cancer
Locally Advanced Pancreatic Cancer With KRAS G12D Mutation
The First Affiliated Hospital with Nanjing Medical University30 enrolled1 locationNCT07438106
Recruiting
Phase 1Phase 2
Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C
Advanced Pancreatic Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.72 enrolled16 locationsNCT06821503
Recruiting
Phase 1Phase 2
Phase I Nab-Paclitaxel Plus Gemcitabine With Proton Therapy for Locally Advanced Pancreatic Cancer (LAPC)
Locally Advanced Pancreatic Cancer
University of Maryland, Baltimore24 enrolled2 locationsNCT03652428
Recruiting
Phase 2
Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Pancreatic Cancer
Advanced Pancreatic Cancer
Hangzhou Converd Co., Ltd.12 enrolled1 locationNCT07006077
Recruiting
Phase 2
IBI343 Combined With Chemotherapy in Advanced Pancreatic Cancer
Advanced Pancreatic Cancers
Zhejiang University64 enrolled2 locationsNCT06770439
Recruiting
Phase 1Phase 2
Liposomal Irinotecan + Oxaliplatin + Bevacizumab Versus Liposomal Irinotecan + 5-FU/LV
Advanced Pancreatic Cancer (Part 1)
Dai, Guanghai138 enrolled2 locationsNCT06782685
Recruiting
Phase 1Phase 2
mFOLFIRINOX Plus Anlotinib and Sintilimab for Advanced Pancreatic Cancer
Metastatic Pancreatic CancerLocally Advanced Pancreatic Cancer
Fujian Provincial Hospital29 enrolled4 locationsNCT06761027
Recruiting
Phase 2
Olaparib in PALB2 Advanced Pancreatic Cancer
Metastatic Pancreatic CancerAdvanced Pancreatic Cancer
Azienda Ospedaliero-Universitaria di Modena16 enrolled1 locationNCT06078787
Recruiting
Phase 2
A Phase 2 Study of ABSK021 in Patients With Advanced Pancreatic Cancer
Advanced Pancreatic Cancer
Abbisko Therapeutics Co, Ltd82 enrolled5 locationsNCT06111274